EATG » R&D

R&D

Drug price transparency: 10 countries back World Health Assembly resolution

Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to…

“Dialogue” highlighted as way forward at closure of WHO Fair Pricing Forum

WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a…

Ageing with HIV Taskforce Meeting: Operationalising Ageing with HIV project R&D Outcomes and Identified Research Gaps

The European AIDS Treatment Group (EATG), held a meeting titled ‘Taskforce meeting: Operationalising Ageing with HIV project R&D Outcomes and identified research gaps' in Frankfurt, Germany, on 21 of March…

G-Finder 2018 report: Neglected disease research and development: Reaching new heights

The 2018 G-Finder report analyzes global investment in research and development (R&D) for neglected diseases. According to the G-Finder 2018 executive summary, the report “provides an up-to-date analysis of how…

New TAG report: Funding for TB research climbed to new high in 2017

December 3, 2018 – Global funding for tuberculosis (TB) research climbed to a previously unreported high of USD $772 million in 2017, according to a report released today by Treatment…

EHVA: European HIV advocates discuss about new clinical study aiming to evaluate experimental strategies for the control of HIV infection

On Thursday, 15th of November, the European AIDS Treatment Group hosted a meeting with members of HIV organisations from six European countries to discuss the launch of the study EHVA…

2018 Access to Medicine Index

The 2018 Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor. Amsterdam, the Netherlands, 20 November…

Continued declines in HIV research funding put global prevention targets at great risk

Madrid, Oct. 25, 2018 – HIV prevention research funding continued to decline in 2017 for the fifth consecutive year, driven largely by a five-year low in US public sector funding, according…

More prevention research needed to control the HIV/AIDS pandemic

Since the beginning of the HIV/AIDS pandemic, investigators have been exploring different avenues of research for how to stop transmission of the virus once and for all. As scientific research…

Effective TB, HIV and malaria vaccines missing from drug development pipeline

Financial modeling tool reveals where global health investment falls short Many of the vaccines critically needed to fight some of the world’s most prevalent infectious diseases are not likely to…